Revvity is trading 6.1% up at $120.82, with sector rotation into healthcare the strongest current explanation.
- It is outperforming the recent August 18, 2026 close of $113.75.
- No fresh company-specific announcement or analyst action clearly explains the move; the latest major catalyst was its August 4 earnings report, which raised 2026 revenue and profit guidance.
- Healthcare was up 3.23% during the regular session, reflecting stronger earnings expectations, favorable regulatory sentiment, and defensive-growth demand.